The Incidence of Treatment-requiring Retinopathy of Prematurity in Greece
NCT ID: NCT05099588
Last Updated: 2023-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
43 participants
OBSERVATIONAL
2020-06-01
2023-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
European Disease Registry on Retinopathy of Prematurity (ROP)
NCT04939571
Retinopathy of Prematurity:Summary of a Decade
NCT01363960
Stress Induced by Screening for Retinopathy of Prematurity - Should Speculum and Indentation Rather be Avoided
NCT04408807
Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity
NCT00000133
Telemedicine Approaches to Evaluating Acute-phase ROP
NCT01264276
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Infants treated for ROP
Other: observational study
Observational study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Other: observational study
Observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Weeks
50 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Athens General Children's Hospital "Pan.&Aglaia Kyriakou", Athens, Greece
UNKNOWN
Agia Sofia Children's Hospital, Athens, Greece
UNKNOWN
Attikon Hospital
OTHER
Iaso Neonatology Clinic, Athens, Greece
UNKNOWN
REA Maternity Hospital, Athens, Greece
UNKNOWN
Ippokratio General Hospital, Thessaloniki, Greece
UNKNOWN
General University Hospital of Patras, Greece
UNKNOWN
General University Hospital of Larisa, Greece
UNKNOWN
University Hospital, Ioannina
OTHER
General University Hospital of Heraklion, Greece
UNKNOWN
Venizeleio General Hospital of Heraklion, Greece
UNKNOWN
General University Hospital of Alexandroupoli, Greece
UNKNOWN
Aristotle University Of Thessaloniki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asimina Mataftsi
Associate Professor in Ophthalmology, Paediatric Ophthalmology and Strabismus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Papageorgiou General Hospital
Thessaloniki, , Greece
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Adams GG, Bunce C, Xing W, Butler L, Long V, Reddy A, Dahlmann-Noor AH. Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk. BMJ Open. 2017 Mar 21;7(3):e013366. doi: 10.1136/bmjopen-2016-013366.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
280/15-04-2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.